Tiber Creek Health Strategies, INC. (on Behalf of Eli Lilly and Company)

Pharmaceutical company.

Based in DC

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $1.6M in lobbying spend across 25 quarterly filings, Tiber Creek Health Strategies, INC. (on Behalf of Eli Lilly and Company) is a significant lobbying presence. Their lobbying covers 8 issue areas. Active from 2020 to 2025.

$1.6M
Total Spend
6
Years Active
1
Firms Hired
8
Lobbyists Deployed
8
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$160K
2021$220K
2022$300K
2023$320K
2024$320K
2025$320K

Issues Lobbied

Health IssuesMedicare/MedicaidImmigrationTradeTaxationCopyright/PatentBudget/AppropriationsEnergy

Lobbying Firms

Tiber Creek Group

Lobbyists

Jonathon JonesJohn GonzalezAndrew MckechnieJennifer OlsonEmily KirlinBryant HallTimothy MolinoCorey Malmgren

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Immigration, Trade, Taxation and 3 more

  • •Issues related to drug pricing.
  • •Issues related to drug pricing. HR 6201 Families First Coronavirus Response Act (PL 116-27); CARES Act - S. 3548 (PL 116-136)
  • •CARES Act - S. 3548 (PL 116-136) - drug pricing issues. H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions Act
  • •Issues related to non-immigrant visa restrictions

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders
🏭 Tech Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.

Similar Clients

GSK (FKA Glaxosmithkline INC.)
$39.9M total spend
Alliance for Retired Americans
$2.5M total spend
Biotechnology Innovation Organization (Formerly Biotechnology Industry Org.)
$2.2M total spend
Sanofi US Services INC (Formerly Known as Genzyme Corporation)
$2.0M total spend
Siemens Healthineers (FKA Varian Medical Systems, INC.)
$1.9M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.